A unified Bayesian framework for interval hypothesis testing in clinical trials

• URL: http://arxiv.org/abs/2402.13890v1
• Date: Wed, 21 Feb 2024 16:01:06 GMT
• Title: A unified Bayesian framework for interval hypothesis testing in clinical trials
• Authors: Abhisek Chakraborty, Megan H. Murray, Ilya Lipkovich, Yu Du
• Abstract summary: The American Statistical Association (ASA) cautioned statisticians against making scientific decisions solely on the basis of traditional P-values. We demonstrate that the interval null hypothesis framework, when used in tandem with Bayes factor-based tests, is instrumental in circumnavigating the key issues of P-values.
• Score: 4.911220423050305
• License: http://creativecommons.org/publicdomain/zero/1.0/
• Abstract: The American Statistical Association (ASA) statement on statistical significance and P-values \cite{wasserstein2016asa} cautioned statisticians against making scientific decisions solely on the basis of traditional P-values. The statement delineated key issues with P-values, including a lack of transparency, an inability to quantify evidence in support of the null hypothesis, and an inability to measure the size of an effect or the importance of a result. In this article, we demonstrate that the interval null hypothesis framework (instead of the point null hypothesis framework), when used in tandem with Bayes factor-based tests, is instrumental in circumnavigating the key issues of P-values. Further, we note that specifying prior densities for Bayes factors is challenging and has been a reason for criticism of Bayesian hypothesis testing in existing literature. We address this by adapting Bayes factors directly based on common test statistics. We demonstrate, through numerical experiments and real data examples, that the proposed Bayesian interval hypothesis testing procedures can be calibrated to ensure frequentist error control while retaining their inherent interpretability. Finally, we illustrate the improved flexibility and applicability of the proposed methods by providing coherent frameworks for competitive landscape analysis and end-to-end Bayesian hypothesis tests in the context of reporting clinical trial outcomes.

Related papers

• Differentially private Bayesian tests [1.3127313002783776]
  We present a novel differentially private Bayesian hypotheses testing framework that arise naturally under a principled data generative mechanism. By focusing on differentially private Bayes factors based on widely used test statistics, we circumvent the need to model the complete data generative mechanism.
  arXiv  Detail & Related papers  (2024-01-27T21:07:11Z)
• Selective Nonparametric Regression via Testing [54.20569354303575]
  We develop an abstention procedure via testing the hypothesis on the value of the conditional variance at a given point. Unlike existing methods, the proposed one allows to account not only for the value of the variance itself but also for the uncertainty of the corresponding variance predictor.
  arXiv  Detail & Related papers  (2023-09-28T13:04:11Z)
• Simultaneous inference for generalized linear models with unmeasured confounders [0.0]
  We propose a unified statistical estimation and inference framework that harnesses structures and integrates linear projections into three key stages. We show effective Type-I error control of $z$-tests as sample and response sizes approach infinity.
  arXiv  Detail & Related papers  (2023-09-13T18:53:11Z)
• Advancing Counterfactual Inference through Nonlinear Quantile Regression [77.28323341329461]
  We propose a framework for efficient and effective counterfactual inference implemented with neural networks. The proposed approach enhances the capacity to generalize estimated counterfactual outcomes to unseen data. Empirical results conducted on multiple datasets offer compelling support for our theoretical assertions.
  arXiv  Detail & Related papers  (2023-06-09T08:30:51Z)
• Causal Discovery via Conditional Independence Testing with Proxy Variables [35.3493980628004]
  The presence of unobserved variables, such as the latent confounder, can introduce bias in conditional independence testing. We propose a novel hypothesis-testing procedure that can effectively examine the existence of the causal relationship over continuous variables.
  arXiv  Detail & Related papers  (2023-05-09T09:08:39Z)
• Excess risk analysis for epistemic uncertainty with application to variational inference [110.4676591819618]
  We present a novel EU analysis in the frequentist setting, where data is generated from an unknown distribution. We show a relation between the generalization ability and the widely used EU measurements, such as the variance and entropy of the predictive distribution. We propose new variational inference that directly controls the prediction and EU evaluation performances based on the PAC-Bayesian theory.
  arXiv  Detail & Related papers  (2022-06-02T12:12:24Z)
• Private Sequential Hypothesis Testing for Statisticians: Privacy, Error Rates, and Sample Size [24.149533870085175]
  We study the sequential hypothesis testing problem under a slight variant of differential privacy, known as Renyi differential privacy. We present a new private algorithm based on Wald's Sequential Probability Ratio Test (SPRT) that also gives strong theoretical privacy guarantees.
  arXiv  Detail & Related papers  (2022-04-10T04:15:50Z)
• On Testability of the Front-Door Model via Verma Constraints [7.52579126252489]
  Front-door criterion can be used to identify and compute causal effects despite unmeasured confounders. Key assumptions -- the existence of a variable that fully mediates the effect of the treatment on the outcome, and which simultaneously does not suffer from similar issues of confounding -- are often deemed implausible. We show that under mild conditions involving an auxiliary variable, the assumptions encoded in the front-door model may be tested via generalized equality constraints.
  arXiv  Detail & Related papers  (2022-03-01T00:38:29Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• Tracking disease outbreaks from sparse data with Bayesian inference [55.82986443159948]
  The COVID-19 pandemic provides new motivation for estimating the empirical rate of transmission during an outbreak. Standard methods struggle to accommodate the partial observability and sparse data common at finer scales. We propose a Bayesian framework which accommodates partial observability in a principled manner.
  arXiv  Detail & Related papers  (2020-09-12T20:37:33Z)
• Balance-Subsampled Stable Prediction [55.13512328954456]
  We propose a novel balance-subsampled stable prediction (BSSP) algorithm based on the theory of fractional factorial design. A design-theoretic analysis shows that the proposed method can reduce the confounding effects among predictors induced by the distribution shift. Numerical experiments on both synthetic and real-world data sets demonstrate that our BSSP algorithm significantly outperforms the baseline methods for stable prediction across unknown test data.
  arXiv  Detail & Related papers  (2020-06-08T07:01:38Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.